搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Arabidopsis thaliana Putative L-type lectin-domain containing receptor kinase V.2 (LECRK52), partial CSB-YP520799DOA
CSB-EP520799DOA
CSB-BP520799DOA
CSB-MP520799DOA
CSB-EP520799DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana UPF0540 protein At1g62060 (At1g62060) CSB-YP520800DOA
CSB-EP520800DOA
CSB-BP520800DOA
CSB-MP520800DOA
CSB-EP520800DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana 50S ribosomal protein L5, chloroplastic (RPL5) CSB-YP520801DOA
CSB-EP520801DOA
CSB-BP520801DOA
CSB-MP520801DOA
CSB-EP520801DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative nucleolar protein 5-3 (NOP5-3) CSB-YP520802DOA
CSB-EP520802DOA
CSB-BP520802DOA
CSB-MP520802DOA
CSB-EP520802DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Solanum lycopersicum Pathogenesis-related genes transcriptional activator PTI6 (PTI6) CSB-YP520803SZY
CSB-EP520803SZY
CSB-BP520803SZY
CSB-MP520803SZY
CSB-EP520803SZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum Gibberellin 20 oxidase 1-A (GA20ox1A) CSB-YP520804TQN
CSB-EP520804TQN
CSB-BP520804TQN
CSB-MP520804TQN
CSB-EP520804TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campanula medium Flavonoid 3',5'-hydroxylase (CYP75A6), partial CSB-YP520805CYW
CSB-EP520805CYW
CSB-BP520805CYW
CSB-MP520805CYW
CSB-EP520805CYW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Catharanthus roseus Deacetoxyvindoline 4-hydroxylase (D4H) CSB-YP520806DQN
CSB-EP520806DQN
CSB-BP520806DQN
CSB-MP520806DQN
CSB-EP520806DQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nicotiana tabacum Serine/threonine-protein phosphatase PP1 isozyme 3 (NPP3) CSB-YP520807NHE
CSB-EP520807NHE
CSB-BP520807NHE
CSB-MP520807NHE
CSB-EP520807NHE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana UMP/CMP kinase (PYR6) CSB-YP520808DOA
CSB-EP520808DOA
CSB-BP520808DOA
CSB-MP520808DOA
CSB-EP520808DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable sucrose-phosphate synthase 1 (SPS1), partial CSB-YP520809DXS
CSB-EP520809DXS
CSB-BP520809DXS
CSB-MP520809DXS
CSB-EP520809DXS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Serine/threonine-protein phosphatase PP2A-5 catalytic subunit (PP2A5) CSB-YP520810DOA
CSB-EP520810DOA
CSB-BP520810DOA
CSB-MP520810DOA
CSB-EP520810DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spinacia oleracea Lon protease homolog 2, peroxisomal, partial CSB-YP520811FKI
CSB-EP520811FKI
CSB-BP520811FKI
CSB-MP520811FKI
CSB-EP520811FKI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Mu-like prophage FluMu transposase A (HI_1478), partial CSB-YP520812HTA
CSB-EP520812HTA
CSB-BP520812HTA
CSB-MP520812HTA
CSB-EP520812HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized glycosyltransferase HI_1698 (HI_1698), partial CSB-YP520813HTA1
CSB-EP520813HTA1
CSB-BP520813HTA1
CSB-MP520813HTA1
CSB-EP520813HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Peptide deformylase 1 (def1) CSB-YP520814DUB
CSB-EP520814DUB
CSB-BP520814DUB
CSB-MP520814DUB
CSB-EP520814DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Penicillin-binding protein 1A (mrcA), partial CSB-YP520815NFZ
CSB-EP520815NFZ
CSB-BP520815NFZ
CSB-MP520815NFZ
CSB-EP520815NFZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus sp. 4-hydroxy-2-oxovalerate aldolase (bphF) CSB-YP520816RLO
CSB-EP520816RLO
CSB-BP520816RLO
CSB-MP520816RLO
CSB-EP520816RLO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Type 2 DNA topoisomerase 6 subunit B (top6B), partial CSB-YP520817FPJ
CSB-EP520817FPJ
CSB-BP520817FPJ
CSB-MP520817FPJ
CSB-EP520817FPJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized HTH-type transcriptional regulator ywrC (ywrC) CSB-YP520818BRJ
CSB-EP520818BRJ
CSB-BP520818BRJ
CSB-MP520818BRJ
CSB-EP520818BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>